Home » Keywords » adhansia-xr

Items Tagged with 'adhansia-xr'

ARTICLES

In Brief: A 16-Hour Ritalin

October 3, 2019

Chris Aiken, MD

Adhansia XR is a new extended-release methylphenidate. Its distinguishing feature is its 16-hour duration.

FDA Approves Adhansia XR

June 11, 2019

Talia Puzantian, PharmD, BCPP and Joshua Feder, MD

Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Geriatric Psychiatry Fact Book, First Edition (2025)
Everything you need to help your older adult patients from the unbiased clinical experts who...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

Child Psychiatry
Helping Kids Feel Safe: Talking About School Shootings
A teen is using substances—how do you decide what kind of treatment makes sense? Outpatient therapy? A more structured program? We’re breaking it down.
Listen now